HK Stock MarketDetailed Quotes

02315 BIOCYTOGEN-B

Watchlist
  • 9.100
  • -0.160-1.73%
Trading May 29 10:04 CST
3.63BMarket Cap-8601P/E (TTM)

BIOCYTOGEN-B Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

BIOCYTOGEN-B Earnings Date

Currency: CNY

Period

FY2023 Annual Report

Mar 27, 2024

Revenue(YoY)

716.91M

+34.28%
EPS(YoY)

-0.96

+38.37%
Analyst Rating

Strong Buy

May 28, 2024

BIOCYTOGEN-B Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/H2-- / 527.015M--
--2024/H1-- / 396.520M--
Mar 27, 20242023/H2390.076M / 367.732M--
Aug 28, 20232023/H1326.836M / 313.852M--
Mar 27, 20232022/H2304.750M / 347.693M--
DatePeriodRevenue/EstimateEarnings Call
--2024/H2-- / 527.015M--
--2024/H1-- / 396.520M--
Mar 27, 20242023/H2390.076M / 367.732M
Live broadcast of Baiosetu's 2023 annual results
03/28 20:00
Replay
Aug 28, 20232023/H1326.836M / 313.852M--
Mar 27, 20232022/H2304.750M / 347.693M
Biosetu-B (2315.HK) 2022 Annual Results Meeting
03/28 20:00
Replay

BIOCYTOGEN-B Earnings Reports

  • BIOCYTOGEN-B: 2023 Annual Report

    Apr 25 04:38

  • BIOCYTOGEN-B: ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2023

    Mar 27 05:05

  • BIOCYTOGEN-B: DATE OF BOARD MEETING

    Mar 15 03:33

  • BIOCYTOGEN-B: 2023 Interim Report

    Sep 26, 2023 03:38

    • Read more

    Analysis

    Analyst Rating

    Updated: May 28, 2024

    Strong Buy

    • Strong Buy

      100.00%

    • Buy

      0.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    HK
    Overall
    Symbol
    Latest Price
    %Chg